Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amarin Corp ADR (NQ: AMRN ) 0.6167 -0.0021 (-0.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amarin Corp ADR < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Looking Into Amarin Corp's Return On Capital Employed May 16, 2022 Amarin Corp (NASDAQ:AMRN) brought in sales totaling $94.63 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 314.74%, resulting in a loss of $31.56 million. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 May 06, 2022 Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading... Via Benzinga A Peek Into The Markets: US Stock Futures Down; Jobs Report In Focus May 06, 2022 Pre-open movers Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022 May 05, 2022 Upgrades Via Benzinga Recap: Amarin Corp Q1 Earnings May 04, 2022 Amarin Corp (NASDAQ:AMRN) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga 10 Biggest Price Target Changes For Thursday May 05, 2022 Needham cut Cirrus Logic, Inc. (NASDAQ: CRUS) price target from $110 to $100. Cirrus Logic shares rose 4.5% to close at $82.81 on Wednesday. Via Benzinga 81 Biggest Movers From Yesterday May 05, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday. Via Benzinga Earnings Scheduled For March 1, 2022 March 01, 2022 Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... Via Benzinga Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5% May 04, 2022 U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision. Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session May 04, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after... Via Benzinga Mid-Day Market Update: Dow Rises 100 Points; Lyft Shares Plummet May 04, 2022 U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. Via Benzinga Mid-Morning Market Update: Markets Mixed; Nasdaq Tumbles 100 Points May 04, 2022 U.S. stocks traded mixed this morning, with the Nasdaq dropping more than 100 points on Wednesday. Via Benzinga The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints May 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 04, 2022 Via Benzinga Amarin Corp's Earnings: A Preview May 03, 2022 Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Amarin Corp... Via Benzinga The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More May 02, 2022 Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... Via Benzinga NASDAQ:AMRN Long Term Investor Notice: Investigation of Potential Wrongdoing at Amarin Corporation Plc March 09, 2022 San Diego, CA -- (SBWIRE) -- 03/09/2022 -- An investigation was announced for investors in shares of Amarin Corporation plc (NASDAQ:AMRN) concerning potential breaches of fiduciary duties by certain... Via SBWire The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution March 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... Via Benzinga Lower Vascepa Volume Hits Amarin's Q4 Topline Growth March 01, 2022 Amarin Corp plc's (NASDAQ: AMRN) Q4 FY21 sales decreased 13.6% Y/Y to $144.49 million, beating the consensus of $141.75 million. The decline was driven primarily by... Via Benzinga Amarin: Q4 Earnings Insights March 01, 2022 Amarin Corp (NASDAQ:AMRN) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight February 27, 2022 Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... Via Benzinga 28 Stocks Moving In Tuesday's Mid-Day Session January 25, 2022 Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,... Via Benzinga 51 Biggest Movers From Yesterday January 26, 2022 Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients... Via Benzinga The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data January 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday January 25, 2022 Good morning, investor! We're starting off the day right with a dive into the biggest pre-market stock movers for Tuesday! Via InvestorPlace NASDAQ: AMRN Investor Notice: Deadline on December 23, 2021in Lawsuit Against Amarin Corporation Plc December 16, 2021 San Diego, CA -- (SBWIRE) -- 12/16/2021 -- A Deadline is coming up on December 23, 2021 in the lawsuit for certain investors in Amarin Corporation plc (NASDAQ: AMRN). Via SBWire Why Amarin Stock Tumbled in November December 07, 2021 The biopharma's stock could be near a bottom after last month's double-digit decline. Via The Motley Fool SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm December 04, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal LAWSUITS FILED AGAINST AMRN, CEI and SBTX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS November 22, 2021 NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... From Jakubowitz Law Via AccessWire Topics Fraud Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HEPS, AMRN and FB November 19, 2021 NEW YORK, NY / ACCESSWIRE / November 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... From The Gross Law Firm Via AccessWire Topics Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.